Hanseatic Management Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Hanseatic Management Services's ALNY Position: Q3 2020 in Review
Hanseatic Management Services sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2020, closing a stake of 6,472 shares — an estimated $959K sold.
Hanseatic Management Services first reported a position in ALNY in Q4 2014 and held it in 12 quarters. The position peaked at $2.73M in Q4 2014. 357 funds tracked by Wall St. Rank hold ALNY as of Q3 2020.
- Hanseatic Management Services reported no remaining Alnylam Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
- Hanseatic Management Services sold 6,472 Alnylam Pharmaceuticals shares in Q3 2020, an estimated $959K.
- Hanseatic Management Services first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 12 quarters.
- Hanseatic Management Services's Alnylam Pharmaceuticals position peaked at $2.73M in Q4 2014.
- 357 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2020.
Based on Hanseatic Management Services's 13F filing for Q3 2020, filed 29 Oct 2020.